Code usapeptidevendors: 25% off everything at · Purgo Labs

Related brand · disclosed

Multi-peptide blend · 3 components

What's in GLOW?

70mg three-peptide vial of GHK-Cu, BPC-157 and thymosin β4.

Multi-Peptide BlendsGlow ComplexUpdated 2026-11-09

Per-vial contents

Combination untested. Marketed for skin research. Purgo's COAs report net content for each component separately.
Original illustration for GLOW (GHK-Cu + BPC-157 + TB-500) research notes: abstract molecular artwork in orange and teal
Original illustration by USA Peptide Vendors; artistic, not a structural model.

What each component does on its own

Evidence level: Components only: no study has tested this combination. All mechanism maps

GLOW mechanism diagramEach component's own reported mechanism, side by side. Targets: GHK-Cu: Cu(II) delivery to cells, BPC-157: VEGFR2, TB-500: G-actin. : . Effect reported for that component alone: Collagen synthesis ↑, Endothelial tube formation, Cell migration.GLOW mechanism mapEach component's own reported mechanism, side by sideGLOW3-component blendGHK-Cu: Cu(II)delivery to cells[1]BPC-157: VEGFR2up-regulation andinternalization [2]TB-500: G-actinmonomer binding (LKKTETQmotif) [3,4]Collagen synthesis ↑fibroblast culture [5]Endothelial tubeformationcell culture [2]Cell migration[4]Evidence: Components only: no study has tested this combination. Numbers in brackets referto the cited sources.usapeptidevendors.com · Research Use OnlyCOMPONENT → REPORTED TARGETEFFECT REPORTED FOR THAT COMPONENT ALONE
Each row comes from studies of that peptide on its own. Whether the blend behaves like the sum of its parts has not been studied. Open SVG
  1. Pickart L et al. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19.
  2. Hsieh MJ et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med. 2017;95:323–333.
  3. Huff T et al. β-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001;33:205–220.
  4. Goldstein AL et al. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12:37–51.
  5. Maquart FX et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238:343-6.

Blend-specific checks

  • Ask for net content per component: GHK-Cu, BPC-157, TB-500. A single purity figure for the vial doesn't cover each peptide.
  • Purgo's COA says “Thymosin Beta-4”; it doesn't state whether that is full-length thymosin β4 or the TB-500 fragment.

FAQ

What is GLOW (GHK-Cu + BPC-157 + TB-500)?

70mg three-peptide vial of GHK-Cu, BPC-157 and thymosin β4. Marketed for skin research. Purgo's COAs report net content for each component separately.

What's in GLOW (GHK-Cu + BPC-157 + TB-500)?

GHK-Cu, BPC-157, TB-500. No published study has tested this exact combination; each component's evidence is separate.

Where can US labs buy GLOW (GHK-Cu + BPC-157 + TB-500)?

Purgo Labs stocks it as “Glow Complex”; code usapeptidevendors takes 25% off at checkout. This page also lists the best-documented second vendor from our 112-vendor directory.

Is research-grade GLOW (GHK-Cu + BPC-157 + TB-500) for human use?

No. Vendor material is sold for Research Use Only, not for human or veterinary use.